CN Patent

CN103813785B — 新的治疗阿片样物质依赖的抗滥用药物组合物

Assigned to Orexo AB · Expires 2017-02-15 · 9y expired

What this patent protects

本发明提供用于治疗如阿片样物质依赖的药物组合物，其包括药理学有效量的丁丙诺啡或其药用盐的微粒，所述微粒与包含弱酸的颗粒或包含弱酸缓冲液形成物质的颗粒关联混合。所述组合物可以进一步包括崩解剂和/或药理学有效量的纳洛酮或其药用盐的颗粒。所述组合物在治疗阿片样物质依赖/成瘾和/或疼痛中有用。

USPTO Abstract

本发明提供用于治疗如阿片样物质依赖的药物组合物，其包括药理学有效量的丁丙诺啡或其药用盐的微粒，所述微粒与包含弱酸的颗粒或包含弱酸缓冲液形成物质的颗粒关联混合。所述组合物可以进一步包括崩解剂和/或药理学有效量的纳洛酮或其药用盐的颗粒。所述组合物在治疗阿片样物质依赖/成瘾和/或疼痛中有用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103813785B
Jurisdiction
CN
Classification
—
Expires
2017-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Orexo AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.